ICOA
XBI icon

Investment Centers of America’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Investment Centers of America’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,356
Closed -$1.42M – 512
2017
Q3 		$1.42M Sell
16,356
-393
-2% -$31.5K 0.1% 174
2017
Q2 		$1.29M Buy
16,749
+904
+6% +$64.1K 0.1% 182
2017
Q1 		$1.1M Buy
+15,845
New +$1.06M 0.08% 215

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Investment Centers of America's XBI Position: Q4 2017 in Review

Investment Centers of America sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 16,356 shares — an estimated $1.42M sold.

Investment Centers of America first reported a position in XBI in Q1 2017 and held it in 3 quarters. The position peaked at $1.42M in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

  • Investment Centers of America reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 16,356 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $1.42M.
  • Investment Centers of America first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 3 quarters.
  • Investment Centers of America's State Street SPDR S&P Biotech ETF position peaked at $1.42M in Q3 2017.
  • 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.